Jason Ehrlich - Jul 6, 2022 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Role: Chief Medical Officer and Chief Development Officer
Signature: /s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich
Stock symbol: KOD
Transactions as of: Jul 6, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/8/2022, 05:23 PM
Previous filing: Jun 17, 2022
Next filing: Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KOD	Stock Option (Right to Buy)	Award	$0	+143K		$0.00	143K	Jul 6, 2022	Common Stock	143K	$8.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-forty-eighth (1/48th) of the shares vest one month after July 1, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Content

One-forty-eighth (1/48th) of the shares vest one month after July 1, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

Remarks:

Chief Medical Officer and Chief Development Officer